atenolol has been researched along with midodrine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Calkins, H | 1 |
| Luu, VD; Wiley, TM | 1 |
| Chen, LY; Shen, WK | 1 |
| Al'bitskaia, KV; Golitsyn, SP; Kheĭmets, GI; Kuchinskaia, EA; Pevzner, AV; Rogoza, AN; Vershuta, EV | 1 |
| Figueroa, JJ; Fischer, PR; Gehrking, JA; Iodice, V; Kimpinski, K; Low, PA; Opfer-Gehrking, TL; Sandroni, P; Singer, W; Sletten, DM | 1 |
| Demir, Y | 1 |
3 review(s) available for atenolol and midodrine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic approaches to therapy for vasovagal syncope.
Topics: Atenolol; Fludrocortisone; Humans; Midodrine; Paroxetine; Randomized Controlled Trials as Topic; Syncope, Vasovagal; Treatment Outcome | 1999 |
Neurocardiogenic syncope: latest pharmacological therapies.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Fluoxetine; Heart Rate; Humans; Midodrine; Patient Education as Topic; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal | 2006 |
1 trial(s) available for atenolol and midodrine
| Article | Year |
|---|---|
[Comparative efficacy and tolerance of atenolol and midodrine in patients with vasovagal syncopes].
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Drug Therapy, Combination; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Midodrine; Syncope, Vasovagal; Tilt-Table Test; Time Factors; Treatment Outcome | 2006 |
4 other study(ies) available for atenolol and midodrine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Recurrent syncope in a 31-year-old army staff sergeant.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Case Management; Humans; Male; Midodrine; Military Personnel; Recurrence; Syncope, Vasovagal; United States | 2002 |
A prospective, 1-year follow-up study of postural tachycardia syndrome.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Inflammatory Agents; Atenolol; Cholinesterase Inhibitors; Female; Fludrocortisone; Follow-Up Studies; Heart Rate; Humans; Male; Metoprolol; Midodrine; Nadolol; Norepinephrine; Postural Orthostatic Tachycardia Syndrome; Propranolol; Prospective Studies; Pyridostigmine Bromide; Severity of Illness Index; Sodium; Tilt-Table Test; Virus Diseases | 2012 |
The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis.
Topics: Antihypertensive Agents; Aryldialkylphosphatase; Atenolol; Atherosclerosis; Humans; Lipoproteins, HDL; Midodrine; Nadolol; Pindolol | 2019 |